| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.3M | -0.6% |
| Cost of Revenue | $1.3M | +16.9% |
| R&D Expense | $8.3M | +7.0% |
| SG&A Expense | $6.9M | +8.3% |
| Operating Income | -$6.6M | -18.3% |
| Pre-tax Income | -$5.6M | -28.3% |
| Income Tax | $257K | +384.9% |
| Net Income | -$5.9M | -32.5% |
| EPS (Basic) | -$0.28 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | -44.0% |
| Accounts Receivable | $3.0M | +3.0% |
| Current Assets | $28.3M | -14.3% |
| Total Assets | $37.2M | -12.8% |
| Current Liabilities | $7.5M | -4.6% |
| Stockholders' Equity | $26.1M | -15.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.4M | -70.8% |
| Capital Expenditures | $165K | +266.7% |
| Investing Cash Flow | -$274K | -104.4% |
| Financing Cash Flow | -$31K | +80.5% |
| Free Cash Flow | -$5.6M | -73.5% |
| -33.3% |
| EPS (Diluted) | -$0.28 | -33.3% |